Hyder Said

Appearances

A LARGE MULTICENTER STUDY ASSESSING FACTORS CAUSING DELAYS IN INITIATING BIOLOGIC OR NOVEL SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
Date
May 8, 2023
BACKGROUND: The impact of pregnancy on vedolizumab (VDZ) and ustekinumab (UST) pharmacokinetics is not well defined. Similarly, the time to infant clearance and outcomes following in-utero exposure require elucidation…
Presenter
Alexander Abadir
Speakers
Konstantinos Papamichail
Angela Troia
Hyder Said
Spurthi Tarugu
Nathan Sairam
Scott Minchenberg
Anna Owings
Adam Parker
Brandon Brousse
Benjamin Billingsley
Alexander Carlyle
Bobby Owens
Pegah Hosseini-Carroll
Joseph Frasca
Sarah Glover
Adam Cheifetz
BIDMC
META-ANALYSIS OF DYE-SPRAYING CHROMOENDOSCOPY COMPARED WITH HIGH DEFINITION WHITE LIGHT ENDOSCOPY IN INFLAMMATORY BOWEL DISEASE-RELATED COLORECTAL CANCER SCREENING
Date
May 6, 2023
Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
Presenter
Hyder Said
Speakers
Mohammed El-Dallal
Vikas Taneja
Shaharyar Zuberi
Kelsey Anderson
Joseph Feuerstein
Beth Israel Deaconess Medical Center